Corticosteroids for heart failure-related cardiogenic shock
Part of Heart & circulation clinical trials.
This study tests whether giving a corticosteroid (an anti-inflammatory medicine) can help people with cardiogenic shock caused by heart failure. It is designed for patients who have high inflammation and are in the ICU early in their hospital stay.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Must be 18 to 80 years old
- Currently in an intensive care unit (ICU)
- Diagnosed with cardiogenic shock caused by heart failure, not a heart attack
- Has a history of chronic heart failure with reduced ejection fraction (LVEF < 40%)
- Has a high level of inflammation (hsCRP ≥ 20 mg/L)
- Admitted to the hospital within the last 48 hours
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tracks how well people with cardiogenic shock (a life-threatening drop in blood flow after a heart attack or heart failure worsening) do when treated with modern support devices and medicines.
This trial is testing different approaches (medications and mechanical support) to help people with acute heart failure and cardiogenic shock (a sudden drop in the heart's pumping ability). It looks at how well these treatments work in a network of hospitals to improve outcomes.
This study looks at how people with cardiogenic shock (or very low blood pressure from heart causes) do after treatment in a specialized cardiovascular ICU. It also examines whether care by heart critical-care specialists affects outcomes.
This registry collects information from patients admitted to the hospital with cardiogenic shock—a serious condition where the heart cannot pump enough blood to the body. Doctors will gather data to better understand what happens to these patients and how to improve their care.
This study compares two treatment strategies for people with unexplained heart failure and irregular heartbeats caused by inflammation: one group gets standard heart medications plus an immune-suppressing steroid (prednisone), and the other gets standard medications alone. Doctors want to see whether adding steroids helps improve heart function and control dangerous heart rhythms.
This study tests whether giving a high dose of a steroid medication (glucocorticoid) early, before reaching the hospital, can help people having a severe type of heart attack called STEMI. If you are having this specific heart attack and meet the criteria, receiving this medication might improve your recovery.
Hear when a new Cardiogenic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.